Literature DB >> 11813569

Helicobacter pylori infection and precancerous lesions of the stomach.

J Valle1, J P Gisbert.   

Abstract

H. pylori infection is associated with a slightly increased risk of gastric cancer. However, the risk is much higher in the subgroup of infected patients who have atrophic gastritis and extensive intestinal metaplasia. In those subjects, H. pylori acts as a trigger of the sequence which begins as atrophic gastritis with intestinal metaplasia and evolves towards immature forms of intestinal metaplasia and dysplasia. It seems that factors different from H. pylori (diet, genetical background, etc.) might have an influence on how often gastric precancerous lesions appear in H. pylori-infected subjects. Effective prevention of gastric carcinoma would require identification of the patients at risk in an early step of the process. Preventive measures would include H. pylori eradication and changes in the diet (i.e., increase of vitamin C and carotenoid intake). Preliminary data suggest that H. pylori eradication cannot revert intestinal metaplasia. However, it is possible that eradication of the bacteria would prevent progression towards immature forms of intestinal metaplasia and dysplasia.

Entities:  

Mesh:

Year:  2001        PMID: 11813569

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay.

Authors:  Kuo-Ching Yang; Alexander Chu; Chao-Sheng Liao; Yu-Min Lin; Gen-Min Wang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

2.  microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.

Authors:  Sui-Han Wang; Xu Li; Li-Sheng Zhou; Zhong-Wei Cao; Chao Shi; Chong-Zhi Zhou; Yu-Gang Wen; Yang Shen; Ji-Kun Li
Journal:  Tumour Biol       Date:  2013-07-20

3.  Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population.

Authors:  Majid Boreiri; Fatemeh Samadi; Arash Etemadi; Masoud Babaei; Emad Ahmadi; Amir Houshang Sharifi; Arash Nikmanesh; Afshin Houshiar; Farhad Pourfarzai; Abbas Yazdanbod; Masoomeh Alimohammadian; Masoud Sotoudeh
Journal:  Arch Iran Med       Date:  2013-06       Impact factor: 1.354

4.  Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.

Authors:  Michael Van Ness; Jeffrey Gregg; Jun Wang; Mingyi Chen
Journal:  J Gastrointest Oncol       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.